SCHEMBL23861442

SCHEMBL23861442

CC(c1ccccc1)(c1c(O)ccc2cc(O)ccc12)c1c(O)ccc2cc(O)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 9/20 0.49
▸ ESR1 P03372 8/20 0.49
▸ CYP3A4 P08684 3/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ CYP2C9 P11712 3/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ HSD17B1 P14061 2/20 0.43
▸ CYP2B6 P20813 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ HSD17B2 P37059 2/20 0.43
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ GFER P55789 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MPL P40238 1/20 0.40
▸ TLR8 Q9NR97 1/20 0.39
▸ NR1I2 O75469 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MIF P14174 1/20 0.37
▸ TYR P14679 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861565 0.92 ESR1 (0.40) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23082053 0.91 ESR1 (0.54) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861444 0.89 ESR1 (0.50) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861415 0.88 ESR1 (0.47) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861639 0.87 CYP1A2 (0.49) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861588 0.85 ESR1 (0.46) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861629 0.84 ESR2 (0.46) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861443 0.83 ESR1 (0.47) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL19806908 0.82 ESR1 (0.47) ESR2ESR1CYP3A4CYP1A2CYP2C9
SCHEMBL23861635 0.81 ESR1 (0.39) ESR2ESR1CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ESR2 1033/4885ESR1 713/4885CYP3A4 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback